Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis

Neurology

Volumn 71, Issue 13, 2008, Pages 974-981

  Tanaka, M ^a   Matsushita, T ^a   Tateishi, T ^a   Ochi, H ^a   Kawano, Y ^a   Mei, F J ^a   Minohara, M ^a   Murai, H ^a   Kira, J I ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CHEMOKINE; CYTOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN P70; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ATOPIC MYELITIS; ATOPY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE ASSOCIATION; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOASSAY; MALE; MULTIPLE SCLEROSIS; MYELITIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SJOEGREN SYNDROME; SPINAL CORD DISEASE; TH2 CELL; UPREGULATION; CEREBROSPINAL FLUID; MIDDLE AGED;

ADULT; CHEMOKINES; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELITIS;

EID: 54049100084     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000326589.57128.c3     Document Type: Article

References (40)

1. Kira J, Yamasaki K, Kawano Y, Kobayashi T. Acute myelitis associated with hyperIgEemia and atopic dermatitis. J Neurol Sci 1997;148:199-203.
2. Kira J, Kawano Y, Yamasaki K, Tobimatsu S. Acute myelitis with hyperIgEaemia and mite antigen specific IgE: atopic myelitis. J Neurol Neurosurg Psychiatry 1998;64: 676-679.
3. Kira J, Kawano Y, Horiuchi I, et al. Clinical, immunological and MRI features of myelitis with atopic dermatitis (atopic myelitis). J Neurol Sci 1999;162:56-61.
4. Osoegawa M, Ochi H, Minohara M, et al. Myelitis with atopic diathesis: a nationwide survey of 79 cases in Japan. J Neurol Sci 2003;209:5-11.
5. Zoli A, Mariano M, Fusari A, Bonifazi F, Antonicelli L. Atopic myelitis: first case report outside Japan? Allergy 2005;60:410-411.
6. Gregoire SM, Mormont E, Laloux P, Godfraind C, Gil-liard C. Atopic myelitis: a clinical, biological, radiological and histopathological diagnosis. J Neurol Sci 2006;247: 231-235.
7. Osoegawa M, Ochi H, Kikuchi H, et al. Eosinophilic myelitis associated with atopic diathesis: a combined neuro-imaging and histopathological study. Acta Neuropathol (Berl) 2003;105:289-295.
8. Ochi H, Wu XM, Osoegawa M, et al. Tc1/Tc2 and Th1/ Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis. J Neuroimmunol 2001;119:297-305.
9. Ochi H, Osoegawa M, Murai H, Minohara M, Taniwaki T, Kira J. Presence of IgE antibodies to bacterial superantigens and increased IL-13-producing T cells in myelitic patients with atopic diathesis. Int Arch Allergy Immunol 2004;134:41-48.
10. Laman JD, van Meurs M, Schellekens MM, et al. Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus). J Neuroimmunol 1998;86:30-45.
11. Lafaille JJ, Keere FV, Hsu AL, et al. Myelin basic proteinspecific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med 1997;186:307-312.
12. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-2112.
13. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
14. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
15. Kira J, Kanai T, Nishimura Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996;40:569-574.
16. Osame M, Matsumoto M, Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol 1987;21:117-122.
17. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjogren syndrome (1999): availability and validity. Mod Rheumatol 2004;14:425-434.
18. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-2069.
19. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007;130:1206-1223.
20. Ishizu T, Osoegawa M, Mei FJ, et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005;128:988-1002.
21. de Jager W, Prakken BJ, Bijlsma JW, Kuis W, Rijkers GT. Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Methods 2005;300:124-135.
22. Conroy DM, Williams TJ. Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res 2001;2:150-156.
23. Louahed J, Zhou Y, Maloy WL, et al. Interleukin 9 promotes influx and local maturation of eosinophils. Blood 2001;97:1035-1042.
24. Gounni AS, Gregory B, Nutku E, et al. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood 2000;96:2163-2171.
25. Musikacharoen T, Oguma A, Yoshikai Y, Chiba N, Masuda A, Matsuguchi T. Interleukin-15 induces IL-12 receptor/β1 gene expression through PU. 1 and IRF3 by targeting chromatin remodeling. Blood 2005;105:711-720.
26. Aoi N, Masuda T, Murakami D, et al. IL-15 prevents allergic rhinitis through reactivation of antigen-specific CD8+ cells. J Allergy Clin Immunol 2006;117:1359-1366.
27. Ishizu T, Minohara M, Ichiyama T, et al. CFS cytokine and chemokine profiles in acute disseminated encephalomyelitis. J Neuroimmunol 2006;175:52-58.
28. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-852.
29. Fiset PO, Leung DY, Hamid Q. Immunopathology of atopic dermatitis. J Allergy Clin Immunol 2006;118:287-290.
30. Akahira-Azuma M, Szczepanik M, Tsuji RF, et al. Early delayed-type hypersensitivity eosinophil infiltrates depend on T helper 2 cytokines and interferon-γ via CXCR3 che-mokines. Immunology 2004;111:306-317.
31. Papadopoulos MC, Manley GT, Krishna S, Verkman AS. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 2004;18:1291-1293.
32. Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000;6:159-163.
33. Miyazato A, Kawakami K, Iwakura Y, Saito A. Chemokine synthesis and cellular inflammatory changes in lungs of mice bearing p40tax of human T-lymphotropic virus type 1. Clin Exp Immunol 2000;120:113-124.
34. Narikawa K, Fujihara K, Misu T, et al. CSF-chemokines in HTLV-1-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha. J Neuroimmunol 2005; 159:177-182.
35. Yamagata T, Mitani K, Ueno H, Kanda Y, Yazaki Y, Hirai H. Triple synergism of human T-lymphotropic virus type 1-encoded tax, GATA-binding protein, and AP-1 is required for constitutive expression of the interleukin-5 gene in adult T-cell leukemia cells. Mol Cell Biol 1997;17: 4272-4281.
36. AhujaJ, Lepoutre V, Wigdahl B, Khan ZK, Jain P. Induction of pro-inflammatory cytokines by human T-cell leukemia virus type-1 Tax protein as determined by multiplexed cytokine protein array analyses of human dendritic cells. Biomed Pharmacother 2007;61:201-208.
37. Alexander GE, Provost TT, Stevens MB, Alexander EL. Sjogren syndrome: central nervous system manifestations. Neurology 1981;31:1391-1396.
38. Cuello C, Palladinetti P, Tedla N, et al. Chemokine expression and leucocyte infiltration in Sjogren's syndrome. Br J Rheumatol 1998;37:779-783.
39. Wang CC, Fu CL, Yang YH, et al. Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma. Gene Ther 2006;13:1414-1421.
40. Redington AE, Roche WR, Madden J, et al. Basic fibroblast growth factor in asthma: measurement in bronchoal-veolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol 2001;107:384-387.